Form 4: Itron SVP Sells Shares Under Pre-Arranged 10b5-1 Plan

Itron's SVP of Outcomes, Donald L. Reeves III, sold 519 shares of common stock for $97.84 per share on February 25, 2026, under a pre-arranged 10b5-1 trading plan.

Summary

• Donald L. Reeves III, Senior Vice President of Outcomes at Itron, Inc. (ITRI), reported the sale of common stock.
• The transactions occurred on February 25, 2026, and involved two separate sales.
• A total of 519 shares were sold at a price of $97.84 per share.
• The sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Reeves on September 11, 2025.
• Following these transactions, Mr. Reeves beneficially owns 29,951 shares of Itron common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale was conducted under a pre-arranged 10b5-1 plan, which is a routine financial planning practice for executives and typically does not signal a change in the company's fundamental outlook.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that insider sales conducted under Rule 10b5-1 plans are a common practice for executives to manage personal finances and diversify holdings in a pre-scheduled, compliant manner. Such transactions are generally viewed as less indicative of management's sentiment about the company's immediate prospects compared to unscheduled open market sales.

Stakeholder Impact

• Shareholders: The transaction represents a minor reduction in an executive's direct ownership, which is a routine event under a 10b5-1 plan and is unlikely to have a significant impact on shareholder sentiment or company valuation.

Key Dates

Recommendation

The Form 4 filing details a pre-scheduled insider stock sale under a 10b5-1 plan, which is a routine financial planning event for executives and typically does not signal a change in the company's fundamental outlook. Therefore, a 'hold' recommendation is appropriate as this transaction does not provide new information to alter an existing investment thesis.

Keywords

Itron, ITRI, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Executive Compensation